Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 25 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 11279703

    Fused pyrimidine compounds as BRD4 and JAK2 dual inhibitors and methods for use thereof

    APTOSE BIOSCIENCES INC. · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted
  2. US 11274077

    4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase

    The United States of America Department of Health · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted
  3. US 11274123

    1,2,4-oxadiazole compounds as inhibitors of CD47 signalling

    Aurigene Discovery Technologies Limited · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted
  4. US 11267782

    Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2α inhibitors

    NIKANG THERAPEUTICS, INC. · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted
  5. US 11267812

    KRAS G12C inhibitors

    Mirati Therapeutics, Inc. · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted
  6. US 11267845

    Inhibitors of CD73-mediated immunosuppression

    Arcus Biosciences, Inc. · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted
  7. US 11261197

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted
  8. US 11261152

    Inhibitors of the N-terminal domain of the androgen receptor

    United States Government as represented by the Department of Veterans Affairs · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted
  9. US 11261231

    Methods for inhibiting HIV or HCV infection by administering TIM-3 binding inhibitors

    The Regents of the University of California · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted
  10. US 11254664

    Benzodiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted
  11. US 11254666

    Compound as GLS1 inhibitor

    Medshine Discovery Inc. · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted
  12. US 11254667

    Substituted imidazo[1,2-A]pyridines as IRAK 1/4 and flt3 inhibitors

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted
  13. US 11254669

    Fused imidazo-piperidine JAK inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted
  14. US 11254683

    Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted
  15. US 11248044

    Methods for altering body composition by administering a GDF8 inhibitor and an Activin A inhibitor

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  16. US 11247971

    Small molecule inhibitors of lactate dehydrogenase and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  17. US 11246859

    Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers

    Biomed Valley Discoveries, Inc. · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  18. US 11247985

    Phenyl indole allosteric inhibitors of P97 ATPase

    The Regents of the University of California · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  19. US 11242333

    Inhibitors of plasma kallikrein

    KalVista Pharmaceuticals Limited · Granted Feb 8, 2022 · Expires Feb 3, 2042

    granted
  20. US 11234939

    Dosage forms comprising a plasma kallikrein inhibitor

    KalVista Pharmaceuticals Limited · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  21. US 11236044

    Selective inhibitors of 12(S)-lipoxygenase (12-LOX) and methods for use of the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  22. US 11236080

    Protein kinase inhibitors

    Princeton Drug Discovery, Inc · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  23. US 11230544

    Substituted 1,3,4-thiadiazoles as GLS1 inhibitors

    Medshine Discovery Inc. · Granted Jan 25, 2022 · Expires Jan 20, 2042

    granted
  24. US 11229679

    Compositions for treating heart disease by inhibiting the action of mAKAPβ

    Anchored RSK3 Inhibitors, LLC · Granted Jan 25, 2022 · Expires Jan 20, 2042

    granted